Fig. 2From: Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancerAscites regression (a, b) is associated with longer OS and PFS in patients with advanced stage HG-SOC who underwent NAC/IDSBack to article page